Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000061

Director sold 20,000 shares at an average $33.83 ($676,583)

From the SEC's structured data for this filing

Trades in this filing

Tessier-Lavigne Marc · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-23 Sale : show line 1 in the form −8,402 $33.40 $280,627 2,035,968 D
2022-03-23 Sale : show line 2 in the form −11,598 $34.14 $395,956 2,024,370 D
Open-market sales · 20,000 sh · avg $33.83 · $676,583
Loading xslF345X03/wf-form4_164824543669895.xml…